Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Adolescent Suicide Attempters (TASA)
NCT00080158Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) and Suicide attempt (3 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Suicidal Event (Suicide Severity Rating Scale) at 24 weeks. Started Mar 2004; status: completed.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)Suicide attempt
Beyond the preview
Go deeper on NCT00080158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080158.